The Global N,N’-Dicyclohexyl Carbodiimide (DCC) Market was valued at USD 43 Million in 2023 and is projected to reach USD 68.44 Million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 5.30% during the forecast period (2024–2032). This growth is being driven by surging demand for peptide synthesis in pharmaceuticals, expanding applications in biochemical reagents and dehydrating condensing processes, and rising needs in nucleic acid production across research institutions and industrial sectors. North America alone, valued at USD 12.25 Million in 2023, is expected to grow at a CAGR of 4.54% from 2025 through 2032, fueled by advanced biotech hubs in the USA and Canada.

As the biotechnology and pharmaceutical industries advance toward more efficient synthesis methods and high-purity reagents, the spotlight falls on the key producers of N,N’-Dicyclohexyl Carbodiimide (DCC), a critical peptide condensing agent (CAS 538-75-0) used in white crystal or light yellow liquid form. These companies are driving innovation in purity levels like 98% and 99%, optimizing supply chains, and meeting demands from biochemical reagent and dehydrating applications. In this blog, we profile the Top 10 Companies in the N,N’-Dicyclohexyl Carbodiimide (DCC) Industry—a mix of pharmaceutical chemical specialists, biotech suppliers, and global manufacturers shaping the future of peptide, nucleic acid, and amikacin synthesis.

---

🔟 1. Shandong Huihai Pharmaceutical and Chemical

Headquarters: Shandong Province, China
Key Offering: High-purity DCC (98% and 99%), Biochemical Reagents

Shandong Huihai Pharmaceutical and Chemical stands as a prominent player in China’s chemical manufacturing landscape, specializing in fine chemicals essential for organic synthesis. The company supplies DCC grades tailored for peptide coupling reactions, serving research labs, pharmaceutical firms, and biotech companies worldwide. With a strong focus on cost-effective production, it caters to the growing Asian market where demand for condensing agents is surging due to expanded drug development activities. Their products are widely used in the synthesis of complex biomolecules, benefiting from the region’s robust manufacturing infrastructure.

Furthermore, Shandong Huihai emphasizes scalability in response to global supply needs, ensuring consistent quality for applications in nucleic acid production and beyond. This positions them well in the competitive environment, particularly as peptide therapeutics gain traction in treatments for chronic diseases.

Innovation Initiatives:

• Expansion of production facilities to meet rising biochemical reagent demands
• Development of custom purity levels for specialized peptide synthesis
• Partnerships with local pharma enterprises for integrated supply chains

Download FREE Sample Report:
N,N’-Dicyclohexyl Carbodiimide (DCC) Market – View in Detailed Research Report

---

9️⃣ 2. Zhejiang Tianyu Pharmaceutical

Headquarters: Zhejiang Province, China
Key Offering: DCC 99% Purity, Dehydrating Condensing Agents

Zhejiang Tianyu Pharmaceutical is a key contributor to the DCC market, leveraging its expertise in pharmaceutical intermediates to produce high-quality reagents. Operating from the innovative Zhejiang region, the company delivers DCC for critical dehydration reactions in peptide and nucleic acid synthesis, supporting both academic research and commercial production. Its products are integral to processes requiring precise coupling efficiency, helping clients achieve higher yields in complex molecular assemblies.

The firm’s strategic location near major ports facilitates exports to Europe and North America, where stringent quality standards drive demand for reliable suppliers. By maintaining rigorous testing protocols, Zhejiang Tianyu ensures its DCC meets international specifications, making it a preferred choice for global biotech applications.

Innovation Initiatives:

• Investment in advanced distillation for ultra-high purity grades
• Collaboration with research institutes on greener synthesis routes
• Enhancement of logistics for faster delivery to international markets

---

8️⃣ 3. Zhejiang Bulk Chemical

Headquarters: Zhejiang Province, China
Key Offering: Bulk DCC 98%, Industrial Condensing Agents

Zhejiang Bulk Chemical excels in large-scale production of DCC, focusing on bulk supplies for industrial applications in biochemical and organic chemistry. Headquartered in China’s chemical hub, the company provides economical solutions for dehydrating condensing agents used in peptide manufacturing and other synthesis processes. Its capacity supports high-volume orders, addressing the needs of emerging markets in South America and the Middle East & Africa.

With a commitment to efficiency, the company optimizes processes to reduce impurities, ensuring compatibility with sensitive downstream reactions. This approach has solidified its role in the value chain, from raw material sourcing to final packaging tailored for lab and pilot-scale use.

Innovation Initiatives:

• Scale-up of manufacturing lines for purity 98% and above
• R&D into cost-optimized production for emerging applications
• Compliance upgrades for global regulatory standards

---

7️⃣ 4. Suzhou Highfine Biotech

Headquarters: Suzhou, Jiangsu Province, China
Key Offering: Biotech-Grade DCC (99%), Peptide Synthesis Reagents

Suzhou Highfine Biotech is at the forefront of biotech-oriented chemical production, offering premium DCC for advanced peptide synthesis. Located in Suzhou’s biotech cluster, the company serves pharmaceutical giants and research organizations with reagents optimized for high-efficiency coupling. Its DCC is particularly valued in the production of therapeutic peptides and amikacin derivatives, where precision is paramount.

The company’s integration of biotechnology expertise allows it to innovate in reagent stability and handling, reducing side reactions in synthesis workflows. This has earned it recognition in Asia-Pacific’s rapidly growing biopharma sector.

Innovation Initiatives:

• Launch of stabilized DCC formulations for prolonged shelf life
• Joint ventures with biotech firms for custom reagent development
• Focus on sustainable manufacturing practices in biotech applications

Download FREE Sample Report:
N,N’-Dicyclohexyl Carbodiimide (DCC) Market – View in Detailed Research Report

---

6️⃣ 5. Zibo Tiantangshan Chemical

Headquarters: Zibo, Shandong Province, China
Key Offering: DCC for Nucleic Acid Synthesis, Various Purities

Zibo Tiantangshan Chemical provides versatile DCC solutions for nucleic acid and peptide applications, drawing on Zibo’s established chemical industry base. The company supplies both standard and specialized grades, supporting research in genomics and proteomics where condensing agents play a vital role. Its products facilitate efficient dehydration in lab-scale to semi-commercial productions.

By emphasizing quality control and traceability, Zibo Tiantangshan meets the demands of regulated markets, contributing to advancements in molecular biology tools and therapeutic development.

Innovation Initiatives:

• Optimization for nucleic acid-specific synthesis protocols
• Capacity expansions to serve growing biotech demands
• Implementation of digital quality monitoring systems

---

5️⃣ 6. Hubei Meibo Technology

Headquarters: Hubei Province, China
Key Offering: High-Purity 99% DCC, Dehydrating Agents

Hubei Meibo Technology is a dynamic force in the DCC arena, specializing in high-purity reagents for demanding biochemical applications. From its base in Hubei, the company exports to Europe and North America, powering peptide synthesis in drug discovery pipelines. Its focus on purity ensures minimal byproducts, enhancing overall process efficiency.

The firm’s agile response to market trends, such as increased amikacin production, positions it as a reliable partner for innovators in pharmaceuticals.

Innovation Initiatives:

• Advanced purification technologies for 99%+ grades
• Strategic alliances with global research labs
• Safety enhancements in handling and storage protocols

---

4️⃣ 7. Atul Ltd.

Headquarters: Valsad, Gujarat, India
Key Offering: Industrial DCC, Biochemical and Condensing Grades

Atul Ltd., one of India’s leading specialty chemical firms, offers DCC for diverse applications in peptide and organic synthesis. With decades of experience, it serves South Asian markets and exports to Southeast Asia, focusing on reliable supply for dehydrating processes. Its robust infrastructure supports consistent delivery amid regional growth in biopharma.

Atul’s emphasis on integrated operations from synthesis to packaging strengthens its competitive edge in the global chain.

Innovation Initiatives:

• Development of eco-friendly synthesis methods
• Expansion into high-purity segments for pharma
• Certifications for international quality standards

---

3️⃣ 8. Kaneka Corporation

Headquarters: Osaka, Japan
Key Offering: Premium DCC 99%, Advanced Biochemical Reagents

Kaneka Corporation brings Japanese precision to the DCC market, producing top-tier reagents for peptide and nucleic acid synthesis. Its global footprint supports research in Japan, Europe, and the USA, where high-purity demands are intense. Kaneka’s DCC excels in critical coupling steps, aiding breakthroughs in biologics.

The company’s technological prowess ensures superior performance, making it a go-to for high-stakes applications.

Innovation Initiatives:

• R&D in next-gen condensing agents
• Global supply network optimizations
• Sustainability-focused production upgrades

---

2️⃣ 9. Tokyo Chemical Industry (TCI)

Headquarters: Tokyo, Japan
Key Offering: Lab-Grade DCC (98-99%), Research Reagents

Tokyo Chemical Industry (TCI), a renowned supplier of organic chemicals, delivers high-quality DCC for laboratory and R&D use worldwide. Specializing in fine chemicals, TCI caters to academic institutions and pharma R&D, with products optimized for small-scale peptide synthesis. Its extensive catalog includes various purities for precise experimentation.

TCI’s reputation for reliability and innovation supports countless research projects globally.

Innovation Initiatives:

• Catalog expansion with specialized DCC variants
• Digital platforms for custom ordering
• Collaborations with universities on new applications

Download FREE Sample Report:
N,N’-Dicyclohexyl Carbodiimide (DCC) Market – View in Detailed Research Report

---

1️⃣ 10. Merck KGaA (Sigma-Aldrich)

Headquarters: Darmstadt, Germany
Key Offering: Ultra-High Purity DCC (99%), Global Biochemical Reagents

Merck KGaA, through its Sigma-Aldrich division, dominates as a global leader in life science reagents, supplying premium DCC for peptide and nucleic acid synthesis. With a vast distribution network, it serves North America, Europe, and Asia-Pacific, meeting the highest standards for pharmaceutical and research needs. Its DCC is pivotal in drug development pipelines worldwide.

Merck’s integrated ecosystem, from production to analytics, ensures unparalleled consistency and support for customers.

Innovation Initiatives:

• Investment in sustainable reagent manufacturing
• Advanced analytics for purity verification
• Strategic partnerships with biotech leaders

Read Full Report:
N,N’-Dicyclohexyl Carbodiimide (DCC) Market – View in Detailed Research Report

---

🌍 Outlook: The Future of N,N’-Dicyclohexyl Carbodiimide (DCC) Is Purer, Greener, and More Efficient

The N,N’-Dicyclohexyl Carbodiimide (DCC) market is poised for steady expansion. While standard grades dominate volumes, investments are pouring into high-purity 99% variants, process optimizations, and sustainable production methods to align with biotech and pharma evolution.

📈 Key Trends Shaping the Market:

• Rapid capacity growth in China and Asia-Pacific dominating supply
• Increasing regulatory demands for purity and safety in reagents
• Digital supply chain enhancements and real-time quality tracking
• Pharma-biotech collaborations accelerating DCC applications

Read Full Report:
N,N’-Dicyclohexyl Carbodiimide (DCC) Market – View in Detailed Research Report

The companies listed above are not only powering peptide synthesis—they’re spearheading the next wave of biochemical innovation.